Ethacridine Inhibits SARS-CoV-2 by Inactivating Viral Particles

Scientists reported the discovery of ethacridine as a potent drug against SARS-CoV-2. Ethacridine was identified via high-throughput screening of an FDA-approved drug library in living cells using a fluorescence assay.